Progenics Pharmaceuticals, Inc. to Present at Lazard Capital Markets Healthcare Conference

Published: Nov 07, 2012

TARRYTOWN, N.Y., Nov. 6, 2012 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) chief executive officer Mark R. Baker will make a presentation on Tuesday, November 13 at 3:30 PM EST at the Lazard Capital Markets 9th Annual Healthcare Conference in New York City. Mr. Baker will provide a company overview, which will be webcast live via a link on the Events page of Progenics' website, and archived there for 90 days.

Back to news